64
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line

, , , , , , , , & show all
Pages 2843-2852 | Published online: 08 Jun 2012

References

  • ParasrampuriaRMehvarRDivergent effects of nitric oxide donors on the biliary efflux transporters in isolated perfused rat livers: nitric oxide-independent inhibition of ABC transporters by sodium nitroprussideDrug Metab Lett201151647221198435
  • LeeCACookJAReynerELSmithDAP-glycoprotein related drug interactions: clinical importance and a consideration of disease statesExpert Opin Drug Metab Toxicol20106560361920397967
  • McDevittCACallaghanRHow can we best use structural information on P-glycoprotein to design inhibitors?Pharmacol Ther2007113242944117208306
  • BinkhathlanZHamdyDABrocksDRLavasanifarAPharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in the ratXenobiotica2010401556119903013
  • LuurtsemaGSchuitRCKlokRPEvaluation of taniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in ratsNucl Med Biol200936664364919647170
  • FriedenbergWRTallmanMSBrodskyIModified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology GroupLeuk Res200428881381915203279
  • AbrahamJEdgerlyMWilsonRA Phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineClin Cancer Res200915103574358219417029
  • IshiiKTanakaSKagamiKEffects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cellsCancer Invest201028322022919863351
  • EnomotoRSuzukiCKoshibaCWogonin prevents immunosuppressive action but not anti-inflammatory effect induced by glucocorticoidAnn N Y Acad Sci2007109541241717404053
  • ChengJWuWChenBAEffect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInt J Nanomedicine2009420921619918367
  • ChengJWangJChenBA promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinInt J Nanomedicine201162123213122114476
  • XiaGChenBDingJEffect of magnetic Fe3O4 nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cellsInt J Nanomedicine201161921192721931487
  • WangLZhangHChenBEffect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cellsInt J Nanomedicine2012778979822359456
  • CollnotEMAliHLehrCMNano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJ Control Release1252012 [Epub ahead of print.]
  • PhilchenkovAAZavelevichMPMikhailenkoVMKuyavaLMApoptosis and content of mobile lipid domains in human leukemia K-562 cells induced to differentiate by quercetin or dimethyl sulfoxideUkr Biokhim Zh2010822104110 Ukrainian20684251
  • JiangZChenBAXiaGHThe reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsInt J Nanomedicine2009410711419516889
  • BattistiRFZhongYFangLModifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistanceMol Pharm20074114015317274671
  • EsteyEHAcute myeloid leukemia: 2012 update on diagnosis, risk stratification, and managementAm J Hematol2012871899922180162
  • LöwenbergBOssenkoppeleGJvan PuttenWHigh-dose daunorubicin in older patients with acute myeloid leukemiaN Engl J Med2009361131235124819776405
  • FernandezHFSunZYaoXAnthracycline dose intensification in acute myeloid leukemiaN Engl J Med2009361131249125919776406
  • HueberAEsserJMKociokNMitomycin C induces multidrug resistance in glaucoma surgeryGraefes Arch Clin Exp Ophthalmol2008246229730417934748
  • GuptaAKWellsSSurface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studiesIEEE Trans Nanobioscience200431667315382647
  • ColeAJYangVCDavidAECancer theranostics: the rise of targeted magnetic nanoparticlesTrends Biotechnol201129732333221489647
  • HoPCGhoseKSavilleDWanwimolrukSEffect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteersEur J Clin Pharmacol2000569–1069369811214778
  • PengJQiQYouQSubchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogsJ Ethnopharmacol2009124225726219397969
  • WongHLBendayanRRauthAMWuXYSimultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancerJ Control Release2006116327528417097178
  • XiongXBMaZLaiRLavasanifarAThe therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicinBiomaterials20103175776819818492